Videos

Videos

17/11/2022

What role does the gut play in the treatment of type 2 diabetes? (FR)

16/11/2022

Microbiota, bariatric surgery: what impact on type 2 diabetes? (FR)

15/11/2022

Living with diabetes: testimony of a patient with type 1 diabetes (FR)

14/11/2022

Type 2 diabetes: causes, diagnosis, treatments (FR)

27/09/2022

MAESTRIA project: artificial intelligence for innovation (EN)

23/09/2022

What are the treatments for familial hypercholesterolemia? (FR)

22/09/2022

What is the status of research into familial hypercholesterolemia? (FR)

21/09/2022

LDL-apheresis treatment for familial hypercholesterolemia (FR)

20/09/2022

ANHET's interview for the HF 2022 week (FR)

19/09/2022

What is familial hypercholesterolemia? 1 in 250 French people are affected by this disease (FR)

21/08/2022

Importance of data interoperability in the MAESTRIA project (EN)

21/08/2022

Lipidomics as a powerful tool for clinical studies (EN)

12/07/2021

Why support the IHU ICAN? (FR)

02/11/2021

What is hypercholesterolemia? (FR)

10/06/2021

How to fight against NASH? (EN/FR)

12/03/2021

Cardiomyocytes derived from reprogrammed iPS from cutaneous fibroblasts (skin)

04/03/2021

Discover the installation of the research MRI of the ICAN Imaging platform (FR)

04/03/2021

What is the role of IHU ICAN? The example of Myriam, 30 years old, overweight (FR)

21/08/2020

What is an IHU? (EN)

21/08/2020

What is the care pathway for Type 2 diabetes? (FR)

21/08/2020

How does the IHU accelerate research? (FR)

21/08/2020

How does IHU improve patient care? (FR)

Communications and Patronage Director

Francine Trocme
f.trocme@ihuican.org
06 81 64 97 88

</p>